Effects of tannins and related polyphenols on superoxide-induced histamine release from rat peritoneal mast cells. 2000

R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Japan.

The effects of tannins and related polyphenols on KO2- and compound 48/80-induced histamine release from rat peritoneal mast cells were examined. Pretreatment with hydrolyzable tannins (1-100 microM) significantly inhibited KO2-induced histamine release. Dimeric ellagitannins, which have hexahydroxydiphenoyl (HHDP) and valoneoyl residues and/or a valoneoyl-related acyl unit in the molecule, showed more potent inhibitory effects than monomeric hydrolyzable tannins. The most effective inhibition was exhibited by agrimoniin and euphorbin C (IC50 0.68 and 0.80 microM), which have dehydrodigalloyl and euphorbinoyl groups, respectively, as well as the HHDP group. However, procyanidins, flavonoids and related polyphenols with small molecular weights, except for epigallocatechin gallate, exhibited negligible effects. Although clinically used antiallergic drugs, azelastine, astemizole, ketotifen and epinastine have been shown to prevent KO2-induced histamine release, their potencies were all less than those of ellagitannins. An inhibitory effect on compound 48/80-induced histamine release was also exhibited by higher molecular weight tannins. The inhibitory effect on histamine release caused by different stimulants suggested that ellagitannins act as cell membrane stabilizers as well as radical scavengers.

UI MeSH Term Description Entries
D008297 Male Males
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D010529 Peritoneal Cavity The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen. Greater Sac,Lesser Sac,Omental Bursa,Bursa, Omental,Cavity, Peritoneal,Sac, Greater,Sac, Lesser
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D003189 p-Methoxy-N-methylphenethylamine A potent mast cell degranulator. It is involved in histamine release. Agent 48-80,BW 48-80,Compound 48-80,Preparation 48-80,Agent 48 80,Agent 4880,BW 48 80,BW 4880,Compound 48 80,Compound 4880,Preparation 48 80,Preparation 4880,p Methoxy N methylphenethylamine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases

Related Publications

R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
May 1994, Biological & pharmaceutical bulletin,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
December 1981, European journal of pharmacology,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
March 2000, The Journal of pharmacy and pharmacology,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
January 1998, Methods and findings in experimental and clinical pharmacology,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
March 2003, European journal of pharmacology,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
September 1993, Agents and actions,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
February 1996, Biological & pharmaceutical bulletin,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
October 1985, European journal of pharmacology,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
September 1982, Klinische Wochenschrift,
R Kanoh, and T Hatano, and H Ito, and T Yoshida, and M Akagi
January 1990, International journal of immunopharmacology,
Copied contents to your clipboard!